Company Ref: 

ASiR–V, is the next iteration of GE Healthcare's iterative reconstruction CT technology, which already has 3,600 installations worldwide and has provided more than 31 million patient scans to date. ASiR-V combines the speed of ASiR with the capabilities of Veo full model-based iterative reconstruction. Designed to significantly reduce dose relative to filtered back-projection (FBP) for both body and head modes, ASiR-V improves low contrast detectability, spatial resolution and image noise, and has the capability to reduce low signal artifacts such as streak artifacts when compared to FBP. ASiR-V is U.S. Food and Drug Administration (FDA) 510(k)-pending and not available for sale.